TABLE 2.

Distribution of P. aeruginosa isolates from the 23 patients of group 2 according to genome macrorestriction type (genotype) and antimicrobial susceptibility profile (antibiotype)

Patient	No. of isolates	Follow-up period (mo)	Genotype (SpeI)a	No. of isolates with the same genotype	Persistence of genotype (mo)	Antibiotypeb
1	4	9	1	1		A
			2	1		B1
			3	1		A
			4	1		A1
2	3	9	5a	2	1	C1, C2
			5b	1		C
3	3	10	6	1		C3
			7	1		A
			8	1		A
4	3	8	9	3	8	A
5	3	12	10	1		A
			11	1		A
			12	1		A
6	4	14	13	2	14	B
			14	2	2	A, A2
7	3	9	15	3	9	A1
8	3	11	16	1		B2
			17	2	3	A, D3
9	3	12	18	1		A
			19	2	2	A
10	3	9	20	2	9	A1, E
			21	1		A
11	6	17	22	6	17	D1, D2
12	7	19	22	6	19	D, D3, F, G
			23	1		G
13	2	3	24	2	3	H
14	4	16	25	4	16	I, F1
15	2	13	35	1		J
			36	1		K
16	5	11	26	1		A
			27	4	11	A
17	3	3	28	3	3	L, M, M1
18	2	4	29	2	4	A
19	3	3	30	3	3	A1, A, B
20	3	11	31a	2	7	N
			31b	1		O
21	2	0	32	2		A1, A3
22	2	2	33	1		M2
			37	1		P
23	4	3	34	4	3	A4, Q

^aIsolates of the same major PFGE pattern are represented by arabic numbers; a letter following the arabic number represents a subtype. 

^bIsolates of the same antibiotype are represented by capital letters; a number following the capital letter represents a subantibiotype.